Journey Medical Corp Interest Expense Nonoperating
Journey Medical Corp (DERM) reported Interest Expense Nonoperating of $906.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-12
- Journey Medical Corp interest expense nonoperating for the quarter ending 2026-06-30 was $906.00K, a 3.31% decline year-over-year.
- Journey Medical Corp interest expense nonoperating for the quarter ending 2026-03-31 was $892.00K, a 0.11% increase year-over-year.
- Journey Medical Corp interest expense nonoperating for the quarter ending 2025-12-31 was $933.00K, a 12.27% increase year-over-year.
- Journey Medical Corp interest expense nonoperating for the quarter ending 2025-09-30 was $937.00K, a 23.61% increase year-over-year.
- Journey Medical Corp interest expense nonoperating for fiscal 2025 was $3.70M, a 36.96% increase from fiscal 2024.
- Journey Medical Corp interest expense nonoperating for fiscal 2024 was $2.70M, a 59.01% increase from fiscal 2023.
- Journey Medical Corp interest expense nonoperating for fiscal 2023 was $1.70M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $906.00K 10-Q · filed 2026-08-12 | $1.80M 10-Q · filed 2026-08-12 | $2.73M derived: sum of 3 quarters · filed 2026-08-12 | $3.67M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $892.00K 10-Q · filed 2026-05-13 | $1.82M derived: sum of 2 quarters · filed 2026-05-13 | $2.76M derived: sum of 3 quarters · filed 2026-05-13 | $3.70M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $933.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $1.87M derived: sum of 2 quarters · filed 2026-03-26 | $2.81M derived: sum of 3 quarters · filed 2026-08-12 | $3.70M 10-K · filed 2026-03-26 |
| 2025-09-30 | $937.00K 10-Q · filed 2025-11-12 | $1.87M derived: sum of 2 quarters · filed 2026-08-12 | $2.77M 10-Q · filed 2025-11-12 | $3.60M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $937.00K 10-Q · filed 2026-08-12 | $1.83M 10-Q · filed 2026-08-12 | $2.66M derived: sum of 3 quarters · filed 2026-08-12 | $3.42M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $891.00K 10-Q · filed 2026-05-13 | $1.72M derived: sum of 2 quarters · filed 2026-05-13 | $2.48M derived: sum of 3 quarters · filed 2026-05-13 | $3.04M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $831.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $1.59M derived: sum of 2 quarters · filed 2026-03-26 | $2.15M derived: sum of 3 quarters · filed 2026-03-26 | $2.70M 10-K · filed 2026-03-26 |
| 2024-09-30 | $758.00K 10-Q · filed 2025-11-12 | $1.32M derived: sum of 2 quarters · filed 2025-11-12 | $1.87M 10-Q · filed 2025-11-12 | $1.89M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $563.00K 10-Q · filed 2025-08-12 | $1.11M 10-Q · filed 2025-08-12 | $1.14M derived: sum of 3 quarters · filed 2025-08-12 | $1.40M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $548.00K 10-Q · filed 2025-05-15 | $572.00K derived: sum of 2 quarters · filed 2025-05-15 | $840.00K derived: sum of 3 quarters · filed 2025-05-15 | $1.60M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $292.00K derived: sum of 2 quarters · filed 2025-03-27 | $1.05M derived: sum of 3 quarters · filed 2025-03-27 | $1.70M 10-K · filed 2025-03-27 |
| 2023-09-30 | $268.00K 10-Q · filed 2024-11-12 | $1.02M derived: sum of 2 quarters · filed 2024-11-12 | $1.67M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $756.00K 10-Q · filed 2024-08-13 | $1.41M 10-Q · filed 2024-08-13 |